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Abstract 
Background: To compare prophylactic use of 
intracameral Moxifloxacin (Vigamox)  with 
subconjuctival injection of Ceftriaxone and 
Dexamethasone in prevention of post operative 
endophthalmitis after cataract extraction with intra 
ocular lens implantation 
Methods: In this comparative study patients with 
uncomplicated cataracts were selected and divided 
into two groups. Each patient of group 1 was given 
an intracameral injection of 500μg/0.1ml 
moxifloxacin (vigamox) and each patient of group 2 
was given subconjunctival injection of ceftriaxone 
and dexamethasone as a last step of the cataract 
extraction surgery with IOL implantation. 
Result: No significant reaction was seen in the 
anterior chamber of the patients during the 6 week 
post operative follow up in 357 patients. One patient 
had significant post operative anterior chamber flare 
and cells without the formation of hypopion. 
Conclusion: Moxifloxacin is effective in 
preventing the post operative endophthalmitis after 
cataract extraction surgery with IOL implantation. 
Key Words: Intracameral Moxifloxacin (Vigamox), 
Subconjuctival Ceftriaxone and Dexamethasone,  
Post Cataract  operation endophthalmitis. 
 
Introduction 
     Postoperative endophthalmitis, a devastating 
condition, can result in loss of vision of the patient. 
The incidence of endophthalmitis after cataract 
surgery is 0.07% to 0.12% and after secondary 
intraocular lens implantation is 0.2% to 0.37%. 1-4 The 
common sources from where the microbes gain access 
in the eye are the eyelids, eye lashes, conjunctiva and 
periocular skin. The most common microorganisms 
harboring in the conjunctival sac are coagulase 
negative staphylococci, corynebacteria, gram negative 
rods and staphylococcus aureus.5 
     To prevent the dreadful complication of 
postoperative endophthalmitis various preventive 
measures are routinely taken which include use of 
preoperative topical antibiotics, disinfecting the 
conjunctival sac and the periocular skin by use of 5% 
ophthalmic solution of povidone iodine and 
meticulous draping and isolation of eyelashes. 
Increasing attention is drawn to the value of an 
intracameral injection of antibiotic at the close of 
cataract surgery to provide immediate, high antibiotic 
levels that are sustained for a period of time. The 
antibiotics that are being used for this purpose are 
vancomycin, cefuroxime and moxifloxacin.6-10 
     Out of these antibiotics that are being used 
moxifloxacin has a broad spectrum of activity  and is 
commercially available in ophthalmic preparation.11 Its 
pH is 6.8 with an osmolality of approximately 290 
mosm/kg, making it compatible with intraocular 
tissue.7 Intracameral use of moxifloxacin has shown no 
toxic effects on corneal endothelium.10  There has been 
seen an increased incidence of cystoid macular edema 
in intracameral use of vancomycin.12 
 
Patients and Methods 
     This comparative study was conducted in 
Department of Ophthalmology, Holy Family Hospital, 
Rawalpindi, from September 2010 to February 2011. 
Detailed examination of the anterior segment and 
posterior segment , of 358 eyes, was performed using 
slit lamp and indirect ophthalmoscope. Patients were 
divided into two groups. Group 1 of 159 eyes received 
intracameral 500µg/0.1ml moxifloxacin as a last step 
of cataract extraction surgery with intraocular lens 
implantation without any subconjuntival injection. 
Groups 2 of 199 eyes received subconjuctival injection 
of ceftriaxone 125mg and dexamethasone 2mg. 
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     The preoperative preparation of the patients 
included cleaning the periocular area and the 
conjunctival sac with 5% ophthalmic solution of 
pyodine and drapping with opsite isolating the 
eyelashes from the operative site. Sealed bottle of 
moxifloxacin eye drops (vigamox) was opened and the 
contents of the container aspirated in a 10cc syringe by 
the operating assistant. 0.1ml of the moxifloxacin 
(vigagmox) eye drops was transferred to 1cc 
tuberculin syringe. This drug was injected in the 
anterior chamber as a last step of the surgery and eye 
was padded.Topical treatment was started 4 hours 
after surgery with tobramycin 3mg/ml and 
dexamethasone 1mg/ml combination eye drops 
instilled 1 drop every two hours and moxifloxacin 
5mg/ml eye drops instilled 1 drop every four 
hours.Postoperative examination of the patients was 
done on first postoperative day, after 1 week, after 3 
weeks and after 6 weeks. Signs of inflammation and 
infection were noted and graded. 
 
Results 
     Mean age of the patients was 60.99 years ± 12.53, 
ranging from 22 years to 100 years. 161 patients were 
male and 197 patients were female. 291 patients 
underwent phacoemulsification with intraocular lens 
implantation and 67 patients had extracapsular 
cataract extraction with intraocular lens 
implantation(Table 1).Patients completed  follow    up  
Table 1:Catararct Extraction with  
IOL-Management 
 Phaco + IOL 
ECCE + 
IOL 
Gender 
Male (Age) 
132(62.02±12.19
) 
29 
(67.24±11.31) 
Female(Age) 
159(59.28±12.67
) 
38 
(60.29±12.46) 
Total 291 67 
IOL 
Foldable 270 0 
Rigid 21 67 
Total 291 67 
Moxifloxacin 
Used 135 24 
Not Used 156 43 
Total 291 67 
Ceftriaxone 
Used 156 43 
Not Used 135 24 
Total 291 67 
Dexa 
Used 161 43 
Not Used 130 24 
Total 291 67 
 
No significant anterior chamber reaction was seen in 
357 patients and anterior chamber flare and cells 
subsided by the 6th week post operative follow up. 
One patient of group 2 had flare of +4 and cells of +3 
on first post operative day without hypopion 
formation. The signs of inflammation subsided in that 
patient at 6th post operative week (Table 2&3). 
Table  2: Cataract Extraction with IOL- Flare 
 in post-operative patients 
 
1st  post-op day 1st Week 
Group-A Group-B Group-A Group-B 
159 199 159 199 
Flare 
0 0 (0%) 0(0%) 126(79.2%) 162(81.4%) 
+1 
127 
(79.9%) 
176 
(88.4%) 
33(20.8%) 36(18.1%) 
+2 32 (20.1%) 22 (11.1%) 0(0%) 0(0%) 
+3 0(0%) 0(0%) 0(0%) 1(0.5%) 
+4 0(0%) 1(0.5%) 0(0%) 0(0%) 
p-value 0.041 0.555 
 
 
3rd Week 6th Week 
Group-A Group-B Group-A Group-B 
159 199 159 199 
Flare 
159(100%) 198(99.5%) 159(100%) 198(99.5%) 159(100%) 
0(0%) 1(0.5%) 0(0%) 1(0.5%) 0(0%) 
0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 
0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 
0(0%) 0(0%) 0(0%) 0(0%) 0(0%) 
p-value 0.371 - 
(Group-A= Vigamox, Group-B=Ceftriaxone) 
 
Table 3:Cataract extract with IOL- Amount of 
cells in post operative patients 
 
1st  post-op day 1st Week 
Group-A Group-B Group-A Group-B 
159 199 159 199 
Cells 
0 0(0%) 0(0%) 101(63.5%) 157(78.9%) 
+1 149(93.7%) 175(87.9%) 0(0%) 0(0%) 
+2 10(6.3%) 23(11.6%) 0(0%) 1(0.5%) 
+3 0(0%) 1(0.5%) 0(0%) 0(0%) 
+4 0(0%) 0(0%) 0(0%) 0(0%) 
± 0(0%) 0(0%) 58(36.5%) 41(20.6%) 
p-value 0.151 0.003 
 
 
1st  post-op day 1st Week 
Group-A Group-B Group-A Group-B 
159 199 159 199 
Cells 
0 159(100%) 198(99.5%) 159(100%) 100(100%) 
+1 0(0%) 0(0%) 0(0%) 0(0%) 
+2 0(0%) 1(0.5%) 0(0%) 0(0%) 
+3 0(0%) 0(0%) 0(0%) 0(0%) 
+4 0(0%) 0(0%) 0(0%) 0(0%) 
± 0(0%) 0(0%) 0(0%) 0(0%) 
p-value 0.371 - 
(Group-A= Vigamox, Group-B=Ceftriaxone) 
 
Discussion 
     Efforts have always been made by ophthalmologists 
to reduce postoperative endophthalmitis, which can 
lead to complete or partial visual loss. Preoperative 
prophylactic measures include disinfecting the 
conjunctival sac and periorbital skin and adenexa with 
use of 5% ophthalmic solution of povidone iodine. 
Using 5% ophthalmic solution of povidone iodine in 
the conjuntival sac reduced the bacterial colonies by 
91% and species by 50%.6,13  
     Gentamycin was  one of the pioneer intracameral 
antibiotic used, after cataract surgery.14 Still a better 
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and more effective antibiotic agent was required to 
prevent the complication of postoperative 
endophthalmitis. A multi center European study was 
conducted in which intracameral cefuroxime was used 
as a last step of cataract sugery.9 However, like 
vancomycin, cefuroxime is available in a systemic 
preparation that must be reconstituted using saline 
solution before it can safely be delivered to the eye. 
Reconstituting the drug for intracameral use may 
increase the risk for toxic anterior segment syndrome 
(TASS) because an undesired concentration of the 
drug may be inadvertently injected if a mistake occurs 
during the preparation or dilution process15. Incorrect 
drug concentration, incorrect pH, and incorrect 
osmolality can cause TASS.16 
     In contrast to vancomycin and cefuroxime, 
moxifloxacin is available in self-preserved commercial 
preparation. Moxifloxacin has a broader spectrum of 
activity against gram positive organisms causing 
endophthalmitis and gives a good coverage against the 
gram negative organisms and anaerobes.11 Its pH is 6.8 
with an osmolality of approximately 290 mOsm/kg 
(product description, moxifloxacin hydrochloride 
ophthalmic solution 0.5%, Alcon Laboratories, 
reference: AAA083–0604) making it compatible with 
intraocular tissue7. Intracameral use of moxifloxacin 
has shown no toxic effects on corneal endothelium.10 It 
has a lower mean inhibitory concentration (MIC) and a 
high mutant prevention concentration (MPC) for most 
bacterial endophthalmitis isolates.14 This MIC level of 
moxifloxacin is maintained in the anterior chamber for 
a period of 5 hours and the level of MPC is maintained 
for 3 hours15 making it an effective antibiotic agent for 
use of prophylaxis of postoperative endophthalmitis. 
Intracameral moxifloxacin is effective in prophylaxis 
of postoperative endophthalmitis. It can be easily 
administered in the anterior chamber at the end of 
cataract surgery. Moxifloxacin can be used safely 
without the risk of damage to the intraocular tissues as 
it is preservative free and has a pH and osmolality 
which is safe for the intraocular tissues 
Conclusion 
The broad spectrum of activity and low mean 
inhibitory concentration of moxifloxacin reduces the 
chance of development of bacterial strains resistant to 
fluoroquinolones. 
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